InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,440.00
(
-0.71%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
72.01
(
1.49%
)
Bitcoin
65,836.29
(
1.00%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: Whosetosay post# 23171

Sunday, 10/21/2012 9:31:09 AM

Sunday, October 21, 2012 9:31:09 AM

Post# of 80490
Does anyone realize that if you do the math and Ponatinib is "premium priced" at $110-$120k per year, we are essentially talking about the difference of about 100 - 110 patients here worldwide in the first year????

It's laughable that some are attributing the sell off to that. I don't think anyone really has any effin clue as to how much Pona is going to sell in the first year. Not even Ariad!

As you said, just one of those days. My buddy has a great saying:

"When they raid the whorehouse, even the piano player has to go".
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up